Trial Enrollment Information
Expanded Access Study of Melphalan CS-PHP with Delcath System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Our Expanded Access Program (EAP) in the United States is now open for enrollment
Ongoing Clinical Trials
At present, we have one ongoing phase 2 clinical trial. This trial is closed to new enrollment.
This study was a phase 2 trial in which patients with unresectable cancers confined to the liver received treatments with melphalan via the Delcath System.
Completed Clinical Trials
Recently completed clinical trials are those that have passed the active data collection and treatment stage, but have not yet been published.
Browse our library of publications and abstracts
Pingpank JF, Libutti SK, Chang R, et al. Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. J Clin Oncol. 2005;23:3465-3474